NCT02201771View on ClinicalTrials.gov

Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Coronary Artery BypassAntiplatelet Agents
Interventions
DRUG

Aspirin

DRUG

Ticagrelor

Trial Locations (6)

200025

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

200092

Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

200433

Changhai Hospital of Shanghai, Shanghai

Unknown

Henan Provincial People's Hospital, Zhengzhou

Jiangsu Province Hospital, Nanjing

Nan Jing First Hospital, Nanjing

All Listed Sponsors
lead

Ruijin Hospital

OTHER

NCT02201771 - Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery | Biotech Hunter | Biotech Hunter